GILEAD SCIENCES, INC. Insider Trading Activity

Also formerly known as GILEAD SCIENCES INC
Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$617.12M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of GILEAD SCIENCES, INC.

Biography of GILEAD SCIENCES, INC.

No biography is available at this moment.

2025-08-08PurchaseAssembly Biosciences, Inc.
ASMB
10 percent owner
2.3M
0.0012%
$0.00$2,296+15.71%
2025-02-18PurchaseArcus Biosciences, Inc.
RCUS
10 percent owner
1.36M
1.2512%
$11.00$15M-4.2%
2024-12-19PurchaseAssembly Biosciences, Inc.
ASMB
10 percent owner
940,499
20.3736%
$21.37$20.1M+9.8%
2024-12-18PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
1.76M
4.8987%
$1.04$1.83M-13.44%
2024-06-17PurchaseAssembly Biosciences, Inc.
ASMB
10 percent owner
179,500
0.0002%
$0.00$180-3%
2024-04-02PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
485,250
0.9047%
$0.76$368,790-35.81%
2024-02-12PurchaseKyverna Therapeutics, Inc. Common Stock
KYTX
10 percent owner
910,000
8.0369%
$22.00$20.02M-75.24%
2024-01-29PurchaseArcus Biosciences, Inc.
RCUS
10 percent owner
15.24M
28.0689%
$21.00$320M+4.25%
2023-06-28PurchaseArcus Biosciences, Inc.
RCUS
10 percent owner
1.01M
1.3257%
$19.26$19.45M-15.57%
2021-01-31PurchaseArcus Biosciences, Inc.
RCUS
10 percent owner
5.65M
9.458%
$39.00$220.35M-12.73%
Total: 10
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.